Antidiabetic Activity of Sulfonamide Derivatives

Sulfonamide-based compounds have garnered significant interest in antidiabetic drug research due to their flexible structures and diverse range of biological effects. This review compiles studies on sulfonamide derivatives evaluated against key targets in type 2 diabetes, including α-glucosidase, α-amylase, DPP-4, and aldose reductase. Research indicates that changes, such as the use of transition metals, the inclusion of halogens, or the mixing of different chemical structures, can significantly affect their activity. Research on the Structure-Activity Relationship (SAR) reveals how the lipophilic, size-related, and electronic properties of these compounds influence their efficacy and selectivity. These substances can enhance insulin responsiveness, lower blood sugar levels, and mitigate problems associated with diabetes, according to animal research and laboratory tests on enzymes. Molecular docking, molecular dynamics, and ADMET predictions are examples of computer-based techniques that help clarify how these molecules interact with their targets and determine whether they are suitable as medications. Overall, the evidence suggests that sulfonamide derivatives can do more than affect carbohydrate-digesting enzymes— they also have antioxidant, anti-inflammatory, and insulin-sensitizing effects. Since they work in several ways, they are strong candidates for new oral treatments for type 2 diabetes. This review emphasizes the importance of integrating chemistry, biological testing, and computer modeling to expedite the development of sulfonamide-based antidiabetic drugs.